BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
-19.02%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$862M
AUM Growth
+$862M
(-38%)
Cap. Flow
-$276M
Cap. Flow
% of AUM
-31.98%
Top 10 Holdings %
Top 10 Hldgs %
52.73%
Holding
87
New
4
Increased
9
Reduced
23
Closed
18
Top Buys
| 1 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$21.1M |
| 2 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$19.8M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$15.2M |
| 4 |
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
|
$13.5M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$7.18M |
Top Sells
| 1 |
Bausch Health
BHC
|
$91.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$30M |
| 3 |
CRDC
CARDICA INC COM NEW (DE)
CRDC
|
$28.4M |
| 4 |
Emergent Biosolutions
EBS
|
$26.9M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$21.7M |
Sector Composition
| 1 | Healthcare | 84.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
KalVista Pharmaceuticals
KALV
$678M
| – | – |
-1,178,941
| Closed | -$4.27M |
|
77
OraSure Technologies
OSUR
$242M
| – | – |
-685,528
| Closed | -$4.42M |
|
|
PTN
78
DELISTED
Palatin Technologies
PTN
| – | – |
-1,368,085
| Closed | -$908K |
|
79
Rigel Pharmaceuticals
RIGL
$697M
| – | – |
-3,125,282
| Closed | -$9.47M |
|
80
Titan Pharmaceuticals
TTNP
$4.84M
| – | – |
-761,201
| Closed | -$3.38M |
|
81
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
0
| – | – |
|
|
ALBO
82
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| – | – |
-2,000,000
| Closed | -$685K |
|
|
AMAG
83
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| – | – |
-300,000
| Closed | -$9.06M |
|
|
GNCA
84
DELISTED
Genocea Biosciences, Inc.
GNCA
| – | – |
-846,243
| Closed | -$4.46M |
|
|
STJ
85
DELISTED
St Jude Medical
STJ
| – | – |
-200,000
| Closed | -$12.4M |
|
|
CYNA
86
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| – | – |
-583,121
| Closed | -$8.92M |
|